Large-scale production and purification
โ
A. Tsai; M. Gallo; T. Petterson; J. Shiloach
๐
Article
๐
1995
๐
Springer
๐
English
โ 576 KB
Immunotoxin therapy for cancer utilizes hybrid proteins composed of a cell targeting moiety which is a monoclonal antibody reactive with the cancer cell surface, and a cytotoxic agent which is either a bacterial or plant toxin, to specifically attack cancer cells. The immunotoxin B3LysPE38, composed